Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer
DOI: 10.2122/gbc.2002.0011

October, 2002

Time to Move on From Current Treatment Strategy?


Adenocarcinoma of the stomach with 800,000 new cases per year worldwide is a major health problem. Despite its declining incidence it remains the second leading cause of cancer-related deaths. The decrease in incidence varies considerably geographically; slow in Asia and developing countries and rapid in the western world. In the USA only 21,600 new cases are expected in 2002 [1:], but the sharply declining incidence-curve in the last five decades shows now a trend toward stabilization [1]. By contrast, incidence in Japan with about 50 new male cases each year per 100,000 population, vs. only 8.7 in the USA, remains one of the highest in the world.

Full Text

Comments and questions? Please contact us.

The Gastric Breast Cancer Network Center is owned, published, and copyrighted 2002. All rights reserved.

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 22 May 2003